We want to keep you up to date with developments in the IP world and let you know what we are up to at Mewburn Ellis.


Second Sight announces market entry in South Korea

17 Jul 2017

Second Sight, a developer, manufacturer and marketer of implantable visual prosthetics has announced its market entry into South Korea.

Autoliv sign agreement with Velodyne to commercialise LiDAR

14 Jul 2017

Autoliv, the global leader in automotive safety systems, has signed an agreement with Velodyne LiDAR for commercialising LiDAR, which is an important sensor technology for autonomous cars.

UK Supreme Court rules on File Wrapper Estoppel and Equivalents

13 Jul 2017

On 12 July, 2017 an important judgement was handed down by the UK Supreme Court in the case of Eli Lilly v Actavis UK. The reasoning in the decision is significant for UK law in two legal areas: file wrapper estoppel and doctrine of equivalents.

OneNucleus: ON Helix Conference

11 Jul 2017

Nick Sutcliffe will be attending the ON Helix conference that takes place on Thursday 13 July in Cambridge. ON Helix is a one day event aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments.

F-star enters into strategic collaboration to develop bispecific antibodies in immuno-oncology

10 Jul 2017

F-star, a biopharmaceutical company developing bispecific antibody immuno-oncology products, has announced a new partnership with a leading science and technology company. This new strategic collaboration will focus on the development and commercialisation of five bispecific immuno-oncology antibodies.

OneNucleus: Business Intelligence Breakfast

04 Jul 2017

Robert Watson will be attending a Business Intelligence Breakfast that takes place on Thursday 6 July in Cambridge. This event will explore how to approach discussions for a proposed collaboration in relation to the disclosure of confidential information (such as intellectual property) to third parties.

Tessa Therapeutics and Parker Institute for Cancer Immunotherapy enter into Strategic Alliance Agreement

03 Jul 2017

Tessa Therapeutics (Tessa) and the Parker Institute for Cancer Immunotherapy (Parker Institute) have announced that they will join forces in a multi-year strategic alliance agreement to jointly advance research into cancer immunotherapy.

Acclaim for Type 1 Clothing: an innovative Manchester brand

30 Jun 2017

Manchester business owner Natalie Balmain has been winning acclaim for her growing enterprise, Type 1 Clothing.

EPO changes rules relating to patentability of plants and animals obtained by essentially biological processes

30 Jun 2017

The EPO has decided to amend the patents rules to exclude plants and animals obtained exclusively by an essentially biological breeding process from patentability.

Examination Success

30 Jun 2017

We are delighted to announce that Tom Furnival, Dan Thornton, Eleanor Maciver and Alex Burns have all passed their European European Qualifying Examinations and are now qualified European Patent Attorneys.

Creo Medical Says First Patient Treated With Speedboat Device

29 Jun 2017

Creo Medical Group PLC announced the first clinical use of its Speedboat device on 22 June.

UK continues UPC ratification process

27 Jun 2017

The UK takes another step towards ratifying the Unified Patent Court (UPC) Agreement by laying the The Unified Patent Court (Immunities and Privileges) Order 2017 before the UK Parliament.

Further Delays for the Unitary Patent Package

23 Jun 2017

The start of the Unitary Patent (UP) and the Unified Patent Court (UPC) has been further delayed. The expected target date of 1 December 2017 cannot be maintained and a start date of mid-2018 (or later) is more likely.

Emerging Technologies Competition 2017 Winners

15 Jun 2017

Congratulations to the winners of the Emerging Technologies Competition 2017.

Cambridge Enterprise CEO receives Lifetime Achievement Award

12 Jun 2017

We congratulate Tony Raven, CEO of Cambridge Enterprise at the University of Cambridge, who has been awarded the Lifetime Achievement Award by Global University Venturing (GUV).